eContinence

eContinence AB is a Swedish medtech company founded in 2021 that develops and manages the Tät® app for treating urinary incontinence based on scientific research from Umeå University. Headquartered in Östersund, the firm provides a medical self-treatment tool designed to help users manage leakage caused by coughing, jumping, or exertion through an evidence-based digital platform.

• Products: The company offers the Tät® app and its specialized variant, Tät-m, which are CE-marked Class I medical devices available in free and premium versions.
• Industries: Their solutions specifically target individuals suffering from stress, urge, and mixed urinary incontinence across various life stages including pregnancy and postpartum recovery.
• Innovation: eContinence has received multiple grants from Vinnova and regional innovation funds to advance the app's features and technical platform since its inception.

The organization continues to expand its reach through strategic partnerships with healthcare networks and research institutions in Sweden.